4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-20-061713
Chief Financial Officer sold 10,000 shares at an average $151.46 ($1,514,612)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McAnear Justin J. · Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-01 | Exercise or conversion : show line 1 in the form | +10,000 | $5.04 | $50,400 | 10,933 | D |
| 2020-12-01 | Sale : show line 2 in the form | −2,624 | $150.03 | $393,680 | 8,309 | D |
| 2020-12-01 | Sale : show line 3 in the form | −3,168 | $150.94 | $478,186 | 5,141 | D |
| 2020-12-01 | Sale : show line 4 in the form | −1,600 | $151.80 | $242,883 | 3,541 | D |
| 2020-12-01 | Sale : show line 5 in the form | −2,108 | $153.21 | $322,965 | 1,433 | D |
| 2020-12-01 | Sale : show line 6 in the form | −500 | $153.79 | $76,897 | 933 | D |
| Open-market sales · 10,000 sh · avg $151.46 · $1,514,612 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-12-01 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −10,000 | $5.04 | 2028-11-02 | 10,000 | 500,000 | D |
Loading xslF345X03/doc4.xml…